I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 31% ± 10% | |
| natural killer cell | 5 studies | 20% ± 6% | |
| hematopoietic precursor cell | 4 studies | 25% ± 8% | |
| plasmablast | 3 studies | 42% ± 13% | |
| conventional dendritic cell | 3 studies | 25% ± 9% | |
| common myeloid progenitor | 3 studies | 29% ± 10% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 19% ± 2% | |
| endothelial cell | 3 studies | 21% ± 8% | |
| dendritic cell | 3 studies | 25% ± 8% | |
| intestinal crypt stem cell | 3 studies | 17% ± 2% | |
| erythrocyte | 3 studies | 30% ± 13% | |
| goblet cell | 3 studies | 19% ± 2% |
